Kiora Pharmaceuticals Inc (KPRX) — Cash Flow Quality Index
Kiora Pharmaceuticals Inc (KPRX) has a Cash Flow Quality Index of -47.49x as of September 2025. Operating cash flow of $-1.27 Million is below net income of $26.81K, suggesting accrual-heavy earnings not yet converted to cash. Also explore Kiora Pharmaceuticals Inc balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kiora Pharmaceuticals Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Kiora Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check KPRX intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Kiora Pharmaceuticals Inc (2024–2024)
Year-by-year earnings quality comparison for Kiora Pharmaceuticals Inc. For live market cap and the full company financial profile, see KPRX company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.38x | $8.56 Million | $3.59 Million | — |